is glp 1 safe for breast cancer survivors Researchers from Penn Medicine found that women taking GLP-1 drugs are less likely to be diagnosed with cancer., @drcelinegounder breaks down the study’s findings and whether the drugs caused GLP-1 Medications and Breast Cancer:

GLP-1 receptor agonists act downstream, targeting the visceral fat accumulation, insulin resistance, and dysregulated appetite that estrogen's absence creates

If you take simvastatin (a cholesterol medication), you should not take a dose higher than 20 mg once daily while taking orforglipron

Put simply: you pay nothing unless we secure compensation for you

Implementation guidance for NHS England proposes a phased rollout of Mounjaro which prioritises patients in greatest need, with an ultimate goal of treating 220,000 patients with Mounjaro in the first three years [6]

GLP-1 and Fatty Liver Disease (NAFLD/NASH) GLP-1RAs show promising benefits in: Hepatic steatosis reduction Weight loss-mediated liver improvement Improved insulin resistance Reduced inflammation These agents are likely to become central therapies in metabolic-associated steatotic liver disease (MASLD)